mRNA

Most Funded Synthetic Biology Companies in 2018

It’s that time of the year again when you start returning or re-gifting all of the plastic crap that got shoved under a slowly dying tree in that annual orgy of consumerism known as Christmas. It’s also the time of year when the media start to hit you with all those year-end lists of the […]

Moderna Stock Offered in Planned IPO

It’s always kind of comical to see financial pundits make a 50/50 call about some binary outcome in the future and then act like they’re the second coming of Nostradamus when the coin happens to land on heads. In the world of finance, it’s easy to pick one side of an outcome and then bring it up […]

Why Moderna Therapeutics Won’t IPO Anytime Soon

We recently wrote an article about 7 publicly traded stocks that are involved in the exciting field of RNA therapeutics or what is often referred to as RNA interference (RNAi). In that article, we noted that not all “RNA therapeutics” companies are created equal and there are actually quite a few categorizations of RNA therapeutics. mRNA is […]

Argos Therapeutics Helps Kidney Cancer Patients Live Longer

Cancer immunotherapy is a treatment that uses a patient’s own immune cells to attack malignant cancer cells. The treatment involves the creation of antibodies that grab onto target proteins that normally prevent immune cells from attacking cancer. By blocking the activity of these proteins, the immune cell is free to fight the disease. Merck, Roche, GlaxoSmithKline, Bristol-Myers Squibb, and others are […]